Elderly Patients Undergoing Surgery During Perioperative Period

Elderly Patients Undergoing Surgery During Perioperative Period: a Prospective Cohort Study

The elderly patients have poorer overall conditions and have lower tolerance to trauma, anesthesia, and surgery. Therefore, the incidence of postoperative complications is relatively higher. In non-cardiac surgeries, approximately 20% of elderly patients experience postoperative complications, and the incidence of postoperative delirium (POD) is 23.8%. This may lead to prolonged hospital stays, increased hospital costs, and affect prognosis and even mortality. The investigators plan to conduct a prospective cohort study by systematically collecting biological samples and clinical information of elderly patients during the perioperative period to explore the possible risk factors and pathogenesis of postoperative delirium and postoperative complications in elderly surgical patients, and to construct a risk prediction model for postoperative complications.

Study Overview

Study Type

Observational

Enrollment (Estimated)

1200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Zhejiang
      • Wenzhou, Zhejiang, China, 325000
        • Recruiting
        • The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Surgical patients aged 65 or above or non-surgical subjects aged 65 or above

Description

Inclusion Criteria:

1) Surgical patients aged 65 or above or non-surgical subjects aged 65 or above. 2) Agree to participate in this study and sign the informed consent form.

Exclusion Criteria:

1)Refused to participate in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Surgical patients aged 65 years or older
For the surgical group patients, questionnaires and scales measuring cognitive function, sleep quality, and quality of life were collected preoperatively, at 1-7 days post-operation, 30 days post-operation, and 1 year post-operation. During the operation, blood, cerebrospinal fluid, and other biological samples from the patients were also collected.
non-surgical subjects aged 65 years or older
For the non-surgical group patients, patients' basic information was collected, along with cognitive scales, sleep scales, and quality of life questionnaires.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of postoperative delirium (POD) within 7 days after surgery
Time Frame: Preoperative, during the first 7 postoperative days
POD is diagnosed daily using the Three-Minute Diagnostic Confusion Assessment Method (3D-CAM).
Preoperative, during the first 7 postoperative days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Days at home up to 30 days after surgery (DAH30)
Time Frame: up to 30 days after surgery
up to 30 days after surgery
Length of hospitalization
Time Frame: till the day of discharge from hospital, an average of 7 days
Length of hospital stay are measured from the anesthesia starting day to the discharge day
till the day of discharge from hospital, an average of 7 days
Economic indicators
Time Frame: during the entire trial, an average of 1 year.
Hospitalization fees; -Preoperative fees; -Anesthesia fees; -Surgery fees; -Post-operative fees; -Post-discharge medical expenses.
during the entire trial, an average of 1 year.
The types of postoperative delirium
Time Frame: Preoperative, during the first 7 postoperative days
The type of delirium is assessed using the Richmond Agitation-Sedation Scale (RASS). The Richmond Agitation-Sedation Scale (RASS) is a 10-point scale ranging from -5 (unarousable) to +4 (combative). A score of +4 represents a combative state where the patient is violent and poses immediate danger, while a score of -5 indicates no response to any stimulus. Based on the RASS score, delirium can be categorized into three motoric subtypes: Hyperactive delirium: RASS scores consistently between +1 and +4. Hypoactive delirium: RASS scores consistently between 0 and -3. Mixed-type delirium: RASS scores that fluctuate between positive and negative values over the observation period.
Preoperative, during the first 7 postoperative days
The severity of postoperative delirium
Time Frame: Preoperative, during the first 7 postoperative days
The severity of postoperative delirium will be assessed using the Confusion Assessment Method-Severity scale (CAM-S).
Preoperative, during the first 7 postoperative days
The duration of postoperative delirium
Time Frame: Preoperative, during the first 7 postoperative days
Duration is defined as the number of days from the onset of delirium symptoms to symptom resolution or hospital discharge, whichever occurs first.
Preoperative, during the first 7 postoperative days
Postoperative neurocognitive dysfunction
Time Frame: preoperative baseline, within 7 days postoperatively, and at 1, 6, and 12 months postoperatively.
Neurocognitive decline is assessed by comparing baseline to postoperative scores on: Mini-Mental State Examination (MMSE, 0-30, higher=better function), Montreal Cognitive Assessment (MoCA, 0-30, higher=better function); and five neuropsychological tests-Clock Drawing Test, (DST, 0-16, higher=better attention), Trail Making Test Parts A and B (TMT-A/B, seconds, lower=better), Boston Naming Test (BNT, 0-30, higher=better naming), Auditory Verbal Learning Test - Huashan version (AVLT-H delayed recall, 0-10, higher=better memory), and Clock Drawing Test (CDT, 0-10, higher=better visuospatial/executive function). Patient/caregiver reports are also collected.
preoperative baseline, within 7 days postoperatively, and at 1, 6, and 12 months postoperatively.
Acute pain
Time Frame: Preoperative and 3 days postoperative.
Using Visual Analogue Scale (VAS), 0-100, 0 means no pain, 100 means severe pain
Preoperative and 3 days postoperative.
Hospital Anxiety and Depression Scale (HADS) score
Time Frame: preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.
The Hospital Anxiety and Depression Scale (HADS) is used for assessment, with each subscale (anxiety or depression) scored from 0-21: "0-7: Non-case", "8-10: Doubtful case", "11-21: Definite case". Higher scores clearly indicate worse outcomes, i.e., more severe anxiety or depression symptoms.
preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.
Activity of Daily Living
Time Frame: preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.
The Activities of Daily Living (ADL) are typically assessed using the Barthel Index. 0-100. A higher score indicates stronger independence: a score of 100 represents complete independence; a score of 61-99 suggests mild functional impairment with basic self-care ability; and a score of ≤40 indicates severe functional impairment, with significant or complete reliance on others for daily living.
preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.
Sleep quality
Time Frame: preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.
Sleep quality is assessed using the Pittsburgh Sleep Quality Index (PSQI). The total score ranges from 0 to 21 points. A score greater than 7 (>7) is typically considered the clinical cutoff for poor sleep quality. A higher score indicates poorer sleep quality.
preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.
The FRAIL Scale
Time Frame: preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.
The FRAIL (Fatigue, Resistance, Ambulation, Illnesses, and Loss of Weight) Scale ranges from 0 to 5. A score of 0 indicates robust/non-frail status, scores of 1-2 indicate pre-frail status, and scores of 3-5 indicate frail status.
preoperative, 5 days, 1 month, 6 months, and 1 year postoperative.
Quality of Life Score
Time Frame: preoperative, 1 month, 6 months, and 1 year postoperative.
using EQ-5D(Score of EuroQol Five Dimensions Questionnaire (EQ-5D)) to measure quality of life
preoperative, 1 month, 6 months, and 1 year postoperative.
Mortality
Time Frame: During hospitalization, 1 month, 6 months, and 1 year postoperative.
In-hospital mortality; 30-day postoperative mortality; 1-year postoperative mortality
During hospitalization, 1 month, 6 months, and 1 year postoperative.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ting Li, MD. PhD, Department of Anaesthesiology and Perioperative Medicine, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 30, 2023

Primary Completion (Estimated)

December 30, 2030

Study Completion (Estimated)

December 30, 2030

Study Registration Dates

First Submitted

December 11, 2025

First Submitted That Met QC Criteria

December 31, 2025

First Posted (Actual)

January 2, 2026

Study Record Updates

Last Update Posted (Actual)

April 1, 2026

Last Update Submitted That Met QC Criteria

March 26, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

Study protocol and statistical analysis plan.

IPD Sharing Time Frame

Beginning 6 months after publication with no end date

IPD Sharing Access Criteria

De-identified participant data underlying the findings will be made available upon reasonable request. Proposals for data access should be directed to the corresponding author (liting1021@aliyun.com).

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Postoperative Complications

Subscribe